Cardiac Resynchronisation Therapy
Cross-source consensus on Cardiac Resynchronisation Therapy from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Comparisons
Highlighted claims
- Cardiac resynchronisation therapy is a core device-based treatment for heart failure patients with ventricular dyssynchrony, especially those with reduced ejection fraction. — Development and real-world cohort validation of a meta-analysis-derived simplified scoring model for cardiac resynchronisation therapy response: a study protocol
- About 30-40% of CRT recipients do not achieve a meaningful clinical response. — Development and real-world cohort validation of a meta-analysis-derived simplified scoring model for cardiac resynchronisation therapy response: a study protocol
- CRT non-response is clinically important because the treatment carries procedural risk, device cost, and resource demands. — Development and real-world cohort validation of a meta-analysis-derived simplified scoring model for cardiac resynchronisation therapy response: a study protocol
- Biventricular pacing remains the first-line standard in major international guidelines despite increased interest in conduction system pacing. — Development and real-world cohort validation of a meta-analysis-derived simplified scoring model for cardiac resynchronisation therapy response: a study protocol